 | • レポートコード：QYR9N7867 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、閉経後骨粗鬆症治療薬のグローバル市場について調査・分析したレポートで、種類別（ビスホスホネート、ホルモン、ストロンチウムラネレート、ラロキシフェン、デノスマブ、その他）、用途別（病院薬局、オンライン薬局、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・閉経後骨粗鬆症治療薬の世界市場規模 ・主要企業別市場シェア ・閉経後骨粗鬆症治療薬の世界市場規模：種類別（ビスホスホネート、ホルモン、ストロンチウムラネレート、ラロキシフェン、デノスマブ、その他） ・閉経後骨粗鬆症治療薬の世界市場規模：用途別（病院薬局、オンライン薬局、小売薬局） ・閉経後骨粗鬆症治療薬のアメリカ市場規模（種類別、用途別） ・閉経後骨粗鬆症治療薬のヨーロッパ市場規模（種類別、用途別） ・閉経後骨粗鬆症治療薬の中国市場規模（種類別、用途別） ・閉経後骨粗鬆症治療薬の日本市場規模（種類別、用途別） ・閉経後骨粗鬆症治療薬の東南アジア市場規模（種類別、用途別） ・閉経後骨粗鬆症治療薬のインド市場規模（種類別、用途別） ・閉経後骨粗鬆症治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・閉経後骨粗鬆症治療薬の世界市場予測（2019年-2025年） ・閉経後骨粗鬆症治療薬の地域別市場予測（2019年-2025年） ... |
Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone.The postmenopausal osteoporosis therapeutics market is expected to register a fast growth over the forecast period owing to the increasing prevalence of postmenopausal osteoporosis disease.
In 2018, the global Postmenopausal Osteoporosis Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Postmenopausal Osteoporosis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Postmenopausal Osteoporosis Therapeutics development in United States, Europe and China.
The key players covered in this study
Eli Lilly
Pfizer
F. Hoffman La Roche
Procter & Gamble
Merck
…
Market segment by Type, the product can be split into
Bisphosphonates
Hormones
Strontium Ranelate
Raloxifene
Denosumab
Others
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Postmenopausal Osteoporosis Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Postmenopausal Osteoporosis Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Postmenopausal Osteoporosis Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Bisphosphonates
1.4.3 Hormones
1.4.4 Strontium Ranelate
1.4.5 Raloxifene
1.4.6 Denosumab
1.4.7 Others
1.5 Market by Application
1.5.1 Global Postmenopausal Osteoporosis Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Postmenopausal Osteoporosis Therapeutics Market Size
2.2 Postmenopausal Osteoporosis Therapeutics Growth Trends by Regions
2.2.1 Postmenopausal Osteoporosis Therapeutics Market Size by Regions (2014-2025)
2.2.2 Postmenopausal Osteoporosis Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Postmenopausal Osteoporosis Therapeutics Market Size by Manufacturers
3.1.1 Global Postmenopausal Osteoporosis Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Postmenopausal Osteoporosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Postmenopausal Osteoporosis Therapeutics Key Players Head office and Area Served
3.3 Key Players Postmenopausal Osteoporosis Therapeutics Product/Solution/Service
3.4 Date of Enter into Postmenopausal Osteoporosis Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Postmenopausal Osteoporosis Therapeutics Market Size by Type (2014-2019)
4.2 Global Postmenopausal Osteoporosis Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Postmenopausal Osteoporosis Therapeutics Market Size (2014-2019)
5.2 Postmenopausal Osteoporosis Therapeutics Key Players in United States
5.3 United States Postmenopausal Osteoporosis Therapeutics Market Size by Type
5.4 United States Postmenopausal Osteoporosis Therapeutics Market Size by Application
6 Europe
6.1 Europe Postmenopausal Osteoporosis Therapeutics Market Size (2014-2019)
6.2 Postmenopausal Osteoporosis Therapeutics Key Players in Europe
6.3 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Type
6.4 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Application
7 China
7.1 China Postmenopausal Osteoporosis Therapeutics Market Size (2014-2019)
7.2 Postmenopausal Osteoporosis Therapeutics Key Players in China
7.3 China Postmenopausal Osteoporosis Therapeutics Market Size by Type
7.4 China Postmenopausal Osteoporosis Therapeutics Market Size by Application
8 Japan
8.1 Japan Postmenopausal Osteoporosis Therapeutics Market Size (2014-2019)
8.2 Postmenopausal Osteoporosis Therapeutics Key Players in Japan
8.3 Japan Postmenopausal Osteoporosis Therapeutics Market Size by Type
8.4 Japan Postmenopausal Osteoporosis Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size (2014-2019)
9.2 Postmenopausal Osteoporosis Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size by Type
9.4 Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size by Application
10 India
10.1 India Postmenopausal Osteoporosis Therapeutics Market Size (2014-2019)
10.2 Postmenopausal Osteoporosis Therapeutics Key Players in India
10.3 India Postmenopausal Osteoporosis Therapeutics Market Size by Type
10.4 India Postmenopausal Osteoporosis Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Postmenopausal Osteoporosis Therapeutics Market Size (2014-2019)
11.2 Postmenopausal Osteoporosis Therapeutics Key Players in Central & South America
11.3 Central & South America Postmenopausal Osteoporosis Therapeutics Market Size by Type
11.4 Central & South America Postmenopausal Osteoporosis Therapeutics Market Size by Application
12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Postmenopausal Osteoporosis Therapeutics Introduction
12.1.4 Eli Lilly Revenue in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Postmenopausal Osteoporosis Therapeutics Introduction
12.2.4 Pfizer Revenue in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 F. Hoffman La Roche
12.3.1 F. Hoffman La Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Postmenopausal Osteoporosis Therapeutics Introduction
12.3.4 F. Hoffman La Roche Revenue in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)
12.3.5 F. Hoffman La Roche Recent Development
12.4 Procter & Gamble
12.4.1 Procter & Gamble Company Details
12.4.2 Company Description and Business Overview
12.4.3 Postmenopausal Osteoporosis Therapeutics Introduction
12.4.4 Procter & Gamble Revenue in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)
12.4.5 Procter & Gamble Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Postmenopausal Osteoporosis Therapeutics Introduction
12.5.4 Merck Revenue in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)
12.5.5 Merck Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Postmenopausal Osteoporosis Therapeutics Key Market Segments
Table Key Players Postmenopausal Osteoporosis Therapeutics Covered
Table Global Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Postmenopausal Osteoporosis Therapeutics Market Size Market Share by Type 2014-2025
Figure Bisphosphonates Figures
Table Key Players of Bisphosphonates
Figure Hormones Figures
Table Key Players of Hormones
Figure Strontium Ranelate Figures
Table Key Players of Strontium Ranelate
Figure Raloxifene Figures
Table Key Players of Raloxifene
Figure Denosumab Figures
Table Key Players of Denosumab
Figure Others Figures
Table Key Players of Others
Table Global Postmenopausal Osteoporosis Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Postmenopausal Osteoporosis Therapeutics Report Years Considered
Table Global Postmenopausal Osteoporosis Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Postmenopausal Osteoporosis Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Postmenopausal Osteoporosis Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Postmenopausal Osteoporosis Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Postmenopausal Osteoporosis Therapeutics Market Share by Regions 2014-2019
Figure Global Postmenopausal Osteoporosis Therapeutics Market Share by Regions 2014-2019
Figure Global Postmenopausal Osteoporosis Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Postmenopausal Osteoporosis Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Postmenopausal Osteoporosis Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Postmenopausal Osteoporosis Therapeutics Market Share by Manufacturers in 2018
Table Global Postmenopausal Osteoporosis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Postmenopausal Osteoporosis Therapeutics Product/Solution/Service
Table Date of Enter into Postmenopausal Osteoporosis Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Postmenopausal Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Postmenopausal Osteoporosis Therapeutics Market Size Share by Type (2014-2019)
Figure Global Postmenopausal Osteoporosis Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Postmenopausal Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Postmenopausal Osteoporosis Therapeutics Market Size Share by Application (2014-2019)
Figure Global Postmenopausal Osteoporosis Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Application in 2018
Figure United States Postmenopausal Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2018-2019)
Table United States Postmenopausal Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Postmenopausal Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table United States Postmenopausal Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Postmenopausal Osteoporosis Therapeutics Market Share by Application (2014-2019)
Figure Europe Postmenopausal Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2018-2019)
Table Europe Postmenopausal Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Postmenopausal Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table Europe Postmenopausal Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Postmenopausal Osteoporosis Therapeutics Market Share by Application (2014-2019)
Figure China Postmenopausal Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2018-2019)
Table China Postmenopausal Osteoporosis Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Postmenopausal Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table China Postmenopausal Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Postmenopausal Osteoporosis Therapeutics Market Share by Application (2014-2019)
Figure Japan Postmenopausal Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2018-2019)
Table Japan Postmenopausal Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Postmenopausal Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table Japan Postmenopausal Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Postmenopausal Osteoporosis Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2018-2019)
Table Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Share by Application (2014-2019)
Figure India Postmenopausal Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2018-2019)
Table India Postmenopausal Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Postmenopausal Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table India Postmenopausal Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Postmenopausal Osteoporosis Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Postmenopausal Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2018-2019)
Table Central & South America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Postmenopausal Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table Central & South America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Postmenopausal Osteoporosis Therapeutics Market Share by Application (2014-2019)
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Postmenopausal Osteoporosis Therapeutics Business (2014-2019) (Million US$)
Figure Eli Lilly Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table F. Hoffman La Roche Company Details
Table F. Hoffman La Roche Revenue in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)(Million US$)
Figure F. Hoffman La Roche Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)
Table F. Hoffman La Roche Recent Development
Table Procter & Gamble Company Details
Table Procter & Gamble Revenue in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)(Million US$)
Figure Procter & Gamble Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)
Table Procter & Gamble Recent Development
Table Merck Company Details
Table Merck Revenue in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Global Postmenopausal Osteoporosis Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Postmenopausal Osteoporosis Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Postmenopausal Osteoporosis Therapeutics Market Size Share by Regions in 2025
Figure United States Postmenopausal Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Postmenopausal Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Postmenopausal Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Postmenopausal Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Postmenopausal Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Postmenopausal Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Postmenopausal Osteoporosis Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Postmenopausal Osteoporosis Therapeutics Market Size by Product (2019-2025)
Figure Global Postmenopausal Osteoporosis Therapeutics Market Size by Product in 2025
Table Global Postmenopausal Osteoporosis Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Postmenopausal Osteoporosis Therapeutics Market Size by Application (2019-2025)
Figure Global Postmenopausal Osteoporosis Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の骨粗鬆症治療薬市場：市場規模・現状・予測 Osteoporosis is a disease where decreased bone strength increases the risk of a broken bone. It is the most common reason for a broken bone among the elderly. Bones that commonly break include the back bones, the bones of the forearm, and the hip. Until a broken bone occurs there are typically no sy…- 世界の女性の健康治療市場：市場規模・現状・予測 Women's experience of health and disease differ from those of men, due to unique biological, social and behavioural conditions. Biological differences vary all the way from phenotype to the cellular, and manifest unique risks for the development of ill health.Rise in cases of infertility and increas…
- 世界の脂質異常症治療薬市場：市場規模・現状・予測 Dyslipidemia is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In this report, Dyslipidemia Therapeutics are divided into statins, non-statins and combinations drugs.In 2018, the global Dyslipidemia Therapeutics market size was xx million US$ an…
- 世界の睡眠障害治療薬市場：市場規模・現状・予測 Sleep disorders result in a lack of deep and restorative sleep.The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. In 2018, the global Sleep Disorder Therapeutics market size was xx…
- 世界の白斑治療学市場：市場規模・現状・予測 Vitiligo is a long-term skin condition characterized by patches of the skin losing their pigment. The patches of skin affected become white and usually have sharp margins. The hair from the skin may also become white.In 2018, the global Vitiligo Therapeutics market size was xx million US$ and it is …